Local activation of immune response in bladder cancer patients treated with intraarterial infusion of recombinant interleukin-2.

Velotti, F; Stoppacciaro, A; Ruco, L; Tubaro, A; Pettinato, A; Morrone, S; Napolitano, T; Bossola, P C; Franks, C R; Palmer, P

Velotti, F; Stoppacciaro, A; Ruco, L; Tubaro, A; Pettinato, A; Morrone, S; Napolitano, T; Bossola, P C; Franks, C R; Palmer, P.

Affiliation

Velotti F; Department of Experimental Medicine, University La Sapienza, Rome, Italy.

Cancer Res ; 51(9): 2456-62, 1991 May 01.

Article in En | MEDLINE | ID: mdl-2015606

Subject(s)

Interleukin-2/therapeutic use; Recombinant Proteins/therapeutic use; Urinary Bladder Neoplasms/immunology; Antigens, CD/immunology; Dose-Response Relationship, Immunologic; Drug Evaluation; Humans; Iliac Artery; Immunity, Cellular; Infusions, Intra-Arterial; Interleukin-2/administration & dosage; Leukocytes/immunology; Lymphocytes, Tumor-Infiltrating/immunology; Recombinant Proteins/administration & dosage; Urinary Bladder Neoplasms/therapy

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Recombinant Proteins / Interleukin-2 Limits: Humans Language: En Journal: Cancer Res Year: 1991 Document type: Article Affiliation country: Italy Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links